1. Signorini V, Elefante E, Zucchi D, et al. One year in review 2020: systemic lupus erythematosus. Clin Exp Rheumatol. 2020;38(4):592-601.
2. Denny DE, Rai S, Jacob SE, Thomas MS. Hypersensitivity reactions and dental considerations-an overview. J Int Dent Med Res. 2021;14(1):360-6.
3. Greenberg M, Glick M. Burket's oral medicine diagnosis and treatment. 11 the ed. Ontario: BC Decker Inc.; 2008.
4. Regezi JA, Sciubba JJ, Jordan RC. Oral pathology: clinical pathologic correlations. 7th ed. St Louis: Elsevier Health Sciences; 2017.
5. Benli M, Batool F, Stutz C, et al. Orofacial manifestations and dental management of systemic lupus erythematosus: A review. Oral Dis. 2021;27(2):151-67. [
DOI:10.1111/odi.13271] [
PMID]
6. Del Barrio-Díaz P, Reyes-Vivanco C, Cifuentes-Mutinelli M, Manríquez J, Vera-Kellet C. Association between oral lesions and disease activity in lupus erythematosus. J Eur Acad Dermatol Venereol. 2020;34(2):349-56. [
DOI:10.1111/jdv.15980] [
PMID]
7. Al-Mutairi KD, Al-Zahrani MS, Bahlas SM, Kayal RA, Zawawi KH. Periodontal findings in systemic lupus erythematosus patients and healthy controls. Saudi Med J. 2015;36(4):463. [
DOI:10.15537/smj.2015.4.10746] [
PMID] [
PMCID]
8. Fabbri C, Fuller R, Bonfá E, et al. Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy. Clin Rheumatol. 2014;33(4):505-9. [
DOI:10.1007/s10067-013-2473-2] [
PMID]
9. Marques C, Maor Y, De Andrade M, Rodrigues V, Benatti B. Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by Toll‐like receptors 2 and 4. Clin Exp Immunol. 2016;183(2):187-92. [
DOI:10.1111/cei.12708] [
PMID] [
PMCID]
10. Hammoudeh M, Al-Momani A, Sarakbi H, Chandra P, Hammoudeh S. Oral Manifestations of systemic lupus erythematosus patients in Qatar: A pilot study. Int J Rheumatol. 2018;2018:6052326. [
DOI:10.1155/2018/6052326] [
PMID] [
PMCID]
11. Handayani R, Subita GP, Pradono SA. Oral mucosal lesions as initial presentation in lupus erythematosus patient (A Case Report). Atlantis Press J. 2018;IDCSU 2017:247-50. [
DOI:10.2991/idcsu-17.2018.63]
12. Maybodi FR, Bashiri H, Sezavar K, Owlia F. Effect of periodontal treatment on serum inflammatory parameters and disease activity in patients with systemic lupus erythematosus: A randomized controlled trial. J Indian Soc Periodontol. 2022;26(6):564-9. [
DOI:10.4103/jisp.jisp_607_21] [
PMID] [
PMCID]
13. Cardoso IL, Leal F, Regis RC. Systemic lupus erythematosus and implications for the oral cavity. J Med Care Res Rev. 2020;3(9):444-53. [
DOI:10.15520/mcrr.v3i9.142]
14. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. [
DOI:10.1002/art.1780400928] [
PMID]
15. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-86. [
DOI:10.1002/art.34473] [
PMID] [
PMCID]
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis and rheumatism. 1992;35(6):630-40. [
DOI:10.1002/art.1780350606] [
PMID]
17. Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri‐implant diseases and conditions-Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018;45(45 Suppl 20):S1-S8. [
DOI:10.1111/jcpe.12935] [
PMID]
18. Chacón-Dulcey V, López-Labady J, Villarroel-Dorrego M, et al. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus. Lupus. 2020;29(7):761-6. [
DOI:10.1177/0961203320922620] [
PMID]
19. Menzies S, O'Shea F, Galvin S, Wynne B. Oral manifestations of lupus. Ir J Med Sci. 2018;187(1):91-3. [
DOI:10.1007/s11845-017-1622-z] [
PMID]
20. Nazarinia MA, Ghaffarpasand F, Shamsdin A, et al. Systemic lupus erythematosus in the Fars province of Iran. Lupus. 2008;17(3):221-7. [
DOI:10.1177/0961203307086509] [
PMID]
21. Wang J, Yang S, Chen J, et al. Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch Dermatol Res. 2007;298(10):485-91. [
DOI:10.1007/s00403-006-0719-4] [
PMID]
22. Aurlene N, Manipal S, Prabu D, Rajmohan. Prevalence of oral mucosal lesions, dental caries, and periodontal disease among patients with systemic lupus erythematosus in a teaching hospital in Chennai, Tamil Nadu. J Family Med Prim Care. 2020;9(7):3374-80. [
DOI:10.4103/jfmpc.jfmpc_1263_19] [
PMID] [
PMCID]
23. Zakeri Z, Narouie B, Bakhshipour A, Sarabadani J. Prevalence of oral manifestations in patient with systemic lupus erythematosus (SLE). Life Sci J. 2012;9(3):1307-11.
24. Rezvaninejad R, Dadmehr M, Rezvaninejad R. Prevalence of oral manifestations in systemic lupus erythematosus patients referred to Shahid Mohammadi Hospital in 2018-2019. Jundishapur J Health Sci. 2021;13(2). e116144 [
DOI:10.5812/jjhs.116144]
25. Villamin CA, Navarra SV. Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus. Mod Rheumatol. 2008;18(2):161-4. [
DOI:10.3109/s10165-008-0029-0]
26. Brennan MT, Valerin MA, Napeñas JJ, Lockhart PB. Oral manifestations of patients with lupus erythematosus. Dent Clin North Am. 2005;49(1):127-41, ix. [
DOI:10.1016/j.cden.2004.07.006] [
PMID]
27. De Rossi SS, Glick M. Lupus erythematosus: considerations for dentistry. J Am Dent Assoc. 1998;129(3):330-9. [
DOI:10.14219/jada.archive.1998.0207] [
PMID]
28. Lourenço SV, de Carvalho FR, Boggio P, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol. 2007;34(7):558-64. [
DOI:10.1111/j.1600-0560.2006.00652.x] [
PMID]
29. Khatibi M, Shakoorpour AH, Jahromi ZM, Ahmadzadeh A. The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus. Lupus. 2012;21(12):1312-5. [
DOI:10.1177/0961203312454589] [
PMID]
30. Chakravarty E, Michaud K, Katz R, Wolfe F. Increased incidence of Herpes Zoster among patients with systemic lupus erythematosus. Lupus. 2013;22(3):238-44. [
DOI:10.1177/0961203312470186] [
PMID]
31. Leite DA GM, Silva OG, Fernandes V, Lima PRTL, Briezinski JP, Dias EP. Prevalence of oral candidiasis in patients with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol. 2012;114(4):e50. [
DOI:10.1016/j.oooo.2012.08.039]
32. de Pablo P, Dewan K, Dietrich T, Chapple I, Gordon C. Periodontal disease is common in patients with systemic lupus erythemathosus. Ann Rheum Dis. 2015;74:1101. [
DOI:10.1136/annrheumdis-2015-eular.6245]
33. Gofur NRP, Handono K, Nurdiana N, Kalim H, Barlianto W. Oral hygiene and dental caries status on systemic lupus erythematosus patients: A cross-sectional study. Pesqui Bras Odontopediatria Clín Integr. 2020;20:0013. [
DOI:10.1590/pboci.2020.116]
34. Loyola Rodriguez JP, Galvan Torres LJ, Martinez Martinez RE, et al. Frequency of dental caries in active and inactive systemic lupus erythematous patients: salivary and bacterial factors. Lupus. 2016;25(12):1349-56. [
DOI:10.1177/0961203316640909] [
PMID]
35. Kudsi, M., Nahas, L.D., Alsawah, R. et al. The prevalence of oral mucosal lesions and related factors in systemic lupus erythematosus patients. Arthritis Res Ther 2021; 23: 229. [
DOI:10.1186/s13075-021-02614-8] [
PMID] [
PMCID]
36. Kole AK, Ghosh A. Cutaneous manifestations of systemic lupus erythematosus in a tertiary referral center. Indian J Dermatol. 2009;54(2):132-6. [
DOI:10.4103/0019-5154.53189] [
PMID] [
PMCID]
37. Saccucci M, Di Carlo G, Bossù M, et al. Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management. J Immunol Res. 2018;2018:6061825. [
DOI:10.1155/2018/6061825] [
PMID] [
PMCID]